Eli Lilly & Co. (LLY) Misses Q1 EPS by 12c; updates guidance
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,208.12 +7.13%
EPS Growth %: +39.6%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: +39.6%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $3.34, $0.12 worse than the analyst estimate of $3.46. Revenue for the quarter came in at $12.73 billion versus the consensus estimate of $12.72 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2025 EPS of $20.78-$22.28, versus the consensus of $22.40. Eli Lilly & Co. sees FY2025 revenue of $58-61 billion, versus the consensus of $59.57 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- TNL Mediagene faces Nasdaq delisting over bid price and equity rules
- U.S. Strikes Iranian Targets In Response To Ship Attack
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
